Thesan Pharmaceuticals Receives $16,000,000 Series A Round

  • Feed Type
  • Date
    11/1/2012
  • Company Name
    Thesan Pharmaceuticals
  • Mailing Address
    392 Camino de Estrella San Clemente, CA 92672
  • Company Description
    Thesan Pharmaceuticals, Inc. is a preclinical biopharmaceutical company dedicated to the development of novel therapeutics for disorders of the skin. Until recently, there has been comparatively limited innovation in the field of dermatology, where many companies have focused on the reformulation of existing drugs often resulting in marginal patient benefit. In contrast, Thesan is focused on the discovery and development of New Chemical Entities that have the potential to provide significantly improved treatment options to patients.
  • Website
    http://www.thesanpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company will focus on the development of novel approaches for the treatment of dermatological disorders.
  • M&A Terms
  • Venture Investor
    Novo A/S
  • Venture Investor
    Novartis Venture Fund

By posting a comment, you agree to our terms and conditions.